English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Myeloid supressor cells
Share :
ASH 2009
3 Dec 2011
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
27 Jan 2010
Views:
8490
Rating:
Save
Rate video
Prof John Harlan - University of Washington, USA
Prof John Harlan talks about the latest in myeloid supressor cells and adapting immune response by targeting the tumour micro-environment.
Categories:
Haematology oncology
Related Videos
OncoAlert Round Up for August 25th - 31st, 2023
Dr Gil Morgan - Executive Director, OncoAlert
4 Sep 2023
Latest in immunological technologies that can treat, control, and prevent cancer
Dr Jill O’Donnell-Tormey - Chief Executive Officer, Cancer Research Institute
16 Aug 2023
Haematology malignancies and cellular therapy
Dr Hugo Fernandez - Moffitt Cancer Center, Tampa, USA
8 Jul 2023
Hodgkin’s and non-Hodgkin’s lymphomas (NHL)
Dr Jose Sandoval Sus - Memorial Healthcare System, Florida, USA
8 Jul 2023
Lisocabtagene maraleucel is efficacious at treating R/R chronic lymphocytic...
Dr Tanya Siddiqi - City of Hope, Duarte, USA
26 Jun 2023
Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment
Dr Nausheen Ahmed - The University of Kansas Cancer, Kansas, USA
23 Jun 2023
Venetoclax and ibrutinib therapy shows favourable results in the treatment of R...
Prof Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands
22 Jun 2023
Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma
Dr Maria-Victoria Mateos - University Hospital Salamanca, Salamanca, Spain
19 Jun 2023
ADCLEC.syn1 and CD33-CARS in humanised acute myeloid leukaemia models shows...
Dr Sascha Haubner - Memorial Sloan Kettering Cancer Center, New York City, USA
19 Jun 2023
More from
e
cancer